Atria (ATRAV) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
5 Jun, 2025Executive summary
Net sales rose to EUR 420.5 million in Q1 2025, up 0.9% year-over-year, with all business areas improving EBIT despite challenging market conditions, especially in Finland.
Consolidated EBIT reached EUR 12.8 million (3.1% margin), an increase of EUR 4.8 million from the prior year, with all business areas showing EBIT growth.
Atria Finland's EBIT was EUR 11.2 million, up EUR 4.0 million, driven by intensified poultry production, new exports to China, and the new Nurmo plant.
A new Group strategy is in preparation, to be published at year-end.
Sustainability efforts recognized, with improved brand perception, SBTI-approved emissions targets, and the first CSRD sustainability report published.
Financial highlights
Net sales: EUR 420.5 million (Q1 2024: EUR 416.8 million).
EBIT: EUR 12.8 million (Q1 2024: EUR 8.0 million), EBIT margin 3.1% (1.9%).
EPS: EUR 0.28 (Q1 2024: EUR 0.10).
Gross profit: EUR 43.3 million, gross margin 10.3% (Q1 2024: 9.2%).
Free cash flow: EUR 11.7 million (Q1 2024: -28.1 million).
Outlook and guidance
Adjusted EBIT for 2025 expected to be lower than 2024 (EUR 65.4 million), due to market volatility and the impact of the April strike.
Geopolitical instability and a recent strike in Finland are expected to impact sales and results for the rest of the year.
Strong market position, brands, and customer relationships support business stability despite challenges.
Latest events from Atria
- Record net sales and EBIT, major investments, and positive 2026 outlook despite market risks.ATRAV
Q4 202512 Feb 2026 - Q3 2025 saw broad-based sales and EBIT growth, major investments, and a raised EBIT outlook.ATRAV
Q3 202523 Oct 2025 - Net sales and EBIT rose, driven by Sweden and poultry efficiency, but 2025 outlook is cautious.ATRAV
Q2 202517 Jul 2025 - Adjusted EBIT up 30% year-over-year, driven by Sweden's growth and operational efficiency.ATRAV
Q3 202413 Jun 2025 - Profitability gains and operational improvements led to a raised EBIT outlook for 2024.ATRAV
Q2 202413 Jun 2025 - Record adjusted EBIT and strong segment gains, but 2025 outlook cautious amid risks.ATRAV
Q4 20245 Jun 2025